https://www.selleckchem.com/pr....oducts/atezolizumab.
8) or overall survival (OS) (P=0.9) when comparing patients who underwent LR versus PD. Multivariable analysis showed that tumor size5cm was the only independent predictor of shorter RFS (P=0.004) and OS (P=0.012). After matching, there was no significant difference in RFS and OS between patients with duodenal versus jejunoileal GISTs (both P0.05). The prognosis of duodenal and jejunoileal GISTs are similar. Recurrence and OS of duodenal GISTs primarily depend on tumor size. For duodenal GISTs, LR is associated with compara
Like
Comment
Share
